LOT · INCREMENTS · PREPARE · TEST · HOLD

Grain Mycotoxin Sampling
Evidence Assurance

A mycotoxin test result is inseparable from the lot and sampling process that created the test portion. Evidence assurance protects lot definition, incremental collection, aggregation, preparation and subdivision, custody, method identity, quality controls, result, uncertainty, hold status and disposition authority.

POPULATIONLOT · FLOW · DISTRIBUTION
SAMPLEINCREMENT · AGGREGATE · SUBSAMPLE
TESTMETHOD · LAB · QUALIFIER
LIMITRESULT ≠ UNSAMPLED GRAIN
EVIDENCEVerified
BRIEFING FLIGHT PLAN / VISUAL READING ROUTE
5CHAPTERS4VISUAL BLOCKS4GRAPH LINKS3SOURCES
HOW TO READ THIS PAGE

Visual explanationA diagram or operating scene makes the relationship visible.

Structured modelA flow, comparison, capability set, or boundary map organizes the idea.

Guided explanationOriginal prose connects the concept to its operating context.

This route describes the briefing's editorial structure. It is not an implementation sequence, maturity score, compatibility claim, or field recommendation.

The sampling design controls
what the result can mean.

FDA identifies mycotoxins as naturally occurring toxins produced by certain molds and maintains regulatory and food-safety context. USDA FGIS handbooks provide official grain sampling and mycotoxin testing procedures within their defined scope.

Mycotoxin evidence remains commodity-, lot-, distribution-, sampling-, preparation-, test-, purpose-, destination-, regulatory- and contract-specific. This briefing explains traceability and does not reproduce procedures, thresholds or disposition rules.

Define, sample, prepare,
test, govern.

01LOT / 01Freeze the sampled populationCommodity and lot, physical boundaries, quantity, container or flow state, origin and history, storage and handling, ownership, intended destination, official or private purpose and exclusions
02SAMPLE / 02Use the authorized designAuthority and current procedure, sampler and equipment, safe access, increment locations or timing, count and pattern only as prescribed, aggregate identity, deviations, seals and custody
03PREPARE / 03Protect reduction and test identityLaboratory or approved site, receipt and condition, preparation and division procedure, equipment and cleaning, test portion identity, method and version, controls, qualifiers, repeats and retained material
04GOVERN / 04Hold and disposition through authorityResult and units, lot linkage, regulatory and contract framework, notification, hold or release, confirmatory path, affected descendants, disposition owner, corrections and records
Read left to right as an explanatory evidence path. Arrows do not encode a protocol, automatic control sequence, compatibility claim, or operating instruction.

A precise test cannot repair
an unrepresentative sample.

LayerCan supportCannot establish alone
Lot definitionThe population intended for inferenceDistribution within that lot
Incremental and aggregate sampleMaterial selected under a defined designPerfect representation of heterogeneous contamination
Prepared test portionMaterial delivered to the analytical methodUnsampled or discarded fractions
Method resultMethod-specific evidence for the test portionAutomatic release, grade or destination decision

Treat every reduction step
as a custody event.

LOT

Prevent identity drift

Link the sampled lot to physical location, quantity, origin, commingling, movements, descendants, ownership, holds and destination.

DESIGN

Use current authorized procedures

Preserve procedure and version, purpose, sampler qualification, equipment, increment record, deviations, safety and reasons for rejection.

REDUCE

Trace sample preparation

Record aggregate, grinding or preparation, mixing and subdivision, equipment cleaning, retained portions, transfers, seals and responsible people.

DECIDE

Separate result from authority

Keep method result, regulatory or contract interpretation, confirmatory testing, hold, release, diversion or disposal as distinct records.

No screen or test result
authorizes unsafe handling.

No sampling procedure, increment count, preparation method, test threshold or disposition rule is provided.Use current USDA, FDA, jurisdictional, buyer, contract, laboratory and qualified professional requirements.

Mycotoxin distribution can be heterogeneous.A result is bounded by lot definition, sampling design, preparation, method and uncertainty; never extend it silently to other material.

Do not enter grain or expose workers to dust and mold to obtain a sample.Use approved sampling equipment, respiratory and grain-handling safety systems and qualified personnel.

See the system around this concept.

Follow incoming and outgoing relationship records to understand what supplies, informs, enables, coordinates with, or extends this technology in the published knowledge graph.

Relationship radar / published edges4 records / 4 neighboring systems
Incoming02records point toward this concept
observe roleGrain Mycotoxin Sampling Evidence AssuranceSelected technology
Outgoing02records point from this concept

04connections visible

01outgoing
observe / Post-harvest systemsGrain Quality and Grade Evidence Assurance adds separately governed sample and laboratory evidence to

Mycotoxin evidence requires its own sampling, method and authority boundary and must not be collapsed into a generic quality label.

Verified2 sources
02incoming
connect / Post-harvest systemsGrain Lot, Inventory, and Custody Assurance defines sampled population, location and descendants for

Mycotoxin evidence requires a stable lot definition and the ability to trace holds and decisions through split, merged and shipped descendants.

Verified2 sources
03incoming
observe / Farm data systemsAgricultural Data Provenance and Lineage Assurance preserves lot, sample, preparation, method and decision lineage for

High-consequence grain results remain auditable when every sample reduction, transfer, test, correction, hold and disposition retains provenance.

Corroborated2 sources
04outgoing
observe / Post-harvest systemsStored-Grain Condition Monitoring adds lot-specific laboratory and hold evidence to

Mycotoxin results can qualify storage review while sensor trends and visible condition cannot predict or replace representative sampling and authorized testing.

Corroborated2 sources
LEARNING ROUTE BRIDGE / THIS NODE IN MOTION
1CONNECTED ROUTE99STEP POSITIONS7ROUTE SOURCE LINKS
Operating practice

Follow grain from harvest through governed storage

Move from harvest context through lot identity, drying, aeration, stored-grain monitoring, inventory reconciliation, representative mycotoxin sampling, holds and governed disposition without issuing dryer settings, storage limits or food and feed safety conclusions.

CURRENT POSITION09
09 / SAMPLE

Understand mycotoxin evidence

Protect lot definition, incremental sampling, aggregation, preparation, method, result and authority boundaries.

Open the complete route ↗
Routes are editorial learning sequences, not implementation orders, product rankings, or field prescriptions. Select a route to see how this technology concept connects to the decisions around it.

Primary sources.

This original briefing uses FDA mycotoxin context and USDA FGIS public handbooks. It reproduces no restricted procedure, sampling table, threshold or method parameter and provides no release, grade, safety or disposition decision.

01
MycotoxinsU.S. Food and Drug Administration · Accessed 2026-08-11
02
Mycotoxin HandbookUSDA Agricultural Marketing Service, Federal Grain Inspection Service · Accessed 2026-08-11
03
Grain Inspection Handbook — Book I: SamplingUSDA Agricultural Marketing Service, Federal Grain Inspection Service · Accessed 2026-08-11
NEXT / AUDIT THE SAMPLE CHAIN

Trace lot, increments, aggregate, preparation, test, result, hold and disposition authority.

Open the mycotoxin audit